BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, May 31, 2026
Home » Topics » Regulatory

Regulatory
Regulatory RSS Feed RSS

1-16-Mojo-lens-hero.png

Mojo Vision’s smart contact lens wins breakthrough device designation from FDA

Jan. 16, 2020
By Meg Bryant
The U.S. FDA has granted breakthrough device designation to Mojo Vision Inc. for its first-of-a-kind true smart contact lens. The Mojo Lens, which features “invisible computing” and a built-in display, enables people to get timely information without having to look away from what they are doing or glance at a screen.
Read More

Regulatory front for Jan. 16, 2020

Jan. 16, 2020
The latest global regulatory news, changes and updates affecting medical devices and technologies.
Read More
Cardiovascular illustration

Cardiologists pushing back on rule to judge appropriateness of stenting

Jan. 16, 2020
By Mark McCarty
Device makers only can watch when cardiologists grapple with federal agency officials over device utilization. However, cardiologists are punching back hard against a rule used to judge whether a coronary artery stent is appropriately used, thus ensuring these devices won’t suffer a significant drop in utilization.
Read More

China promotes real-world evidence in R&D and approval with new guidelines

Jan. 16, 2020
By Elise Mak
BEIJING – China has released guidelines to promote the use of real-world evidence (RWE) in drug development and reviews.
Read More

Regulatory front for Jan. 16, 2020

Jan. 16, 2020
The latest global regulatory news, changes and updates affecting biopharma.
Read More

European Commission grants marketing authorization for Isturisa

Jan. 16, 2020
Map of Europe

EU posts guidelines for medical device cybersecurity

Jan. 15, 2020
By Nuala Moran
LONDON – The European Commission has published new guidelines on cybersecurity for medical devices, putting flesh on the bones of the requirements in the Medical Device Regulation (MDR) that comes into force in May.
Read More

Regulatory front for Jan. 15, 2020

Jan. 15, 2020
The latest global regulatory news, changes and updates affecting biopharma.
Read More

Regulatory front for Jan. 14, 2020

Jan. 14, 2020
The latest global regulatory news, changes and updates affecting medical devices and technologies.
Read More
1-14-Transenterix-Senhance.png

Transenterix seeks FDA clearance of first machine vision system for robotic surgery

Jan. 14, 2020
By Meg Bryant
Transenterix Inc., of Research Triangle Park, N.C., said Tuesday that it has filed a 510(k) submission with the U.S. FDA for the Intelligent Surgical Unit (ISU), a machine vision system designed to work with its robotic Senhance surgical system. The new technology would equip users of the Senhance system with augmented intelligence to improve performance and surgical outcomes.
Read More
Previous 1 2 … 951 952 953 954 955 956 957 958 959 … 1368 1369 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 29, 2026.
  • Floating antibody drug conjugates

    TROP2 ADCs progress into first-line for lung, breast cancers

    BioWorld
    Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
  • Illustration of antibodies and viral infection

    New evidence links autoimmunity to long COVID symptoms

    BioWorld
    Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
  • Digital brain and silhouette

    Will Ovid’s golden age of KCC2 metamorph CNS?

    BioWorld
    The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
  • U.S. Capitol building

    BMS-Hengrui deal strikes panic in Washington

    BioWorld
    On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing